Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, announced the opening of its new global corporate headquarters in Tampa, Fla. The state-of-the-art site has been designed to showcase innovation, collaboration and excellence, supporting the Company’s commitment to driving value for its pharmaceutical, biotech and consumer health customers through unparalleled service excellence and a Patient First mindset.
“The opening of our new global headquarters in Tampa is an important milestone that reflects our aspirations for continued growth and recognizes our heritage as an organization built on innovation, service excellence and integrity,” said Alessandro Maselli, President & Chief Executive Officer of Catalent. “For nearly half a century, we have enjoyed a presence in the Tampa region where today we provide services ranging from early phase development to full-scale commercial manufacturing at our St. Petersburg site. We are excited to expand our presence in the region.”